Picture of Oncoinvent ASA logo

ONCIN — Oncoinvent ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Bergenbio Provides Update On Bemcentinib's Involvement In Potential Treatment Of COVID-19 Pandemic

July 28 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * UPDATE ON BEMCENTINIB'S INVOLVEMENT IN POTENTIAL TREATMENT OF COVID-19 PANDEMIC
    * CONFIRMS CO IS IN LATE STAGE SET-UP PHASE TO SPONSOR AND CONDUCT A SIMILAR STUDY TO ACCORD
IN A
COUNTRY OF HIGH COVID-19 INCIDENCE
    * UNIVERSITY HOSPITAL SOUTHAMPTON NHS TRUST HAS NOTIFIED ALL SITES IN ACCORD STUDY TO CEASE
RECRUITMENT OF NEW PATIENTS INTO TRIAL

Source text for Eikon:  ID:nWkr9nwvwb 
Further company coverage:  BGBIO.OL 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Oncoinvent ASA

See all news